Gittelman MC - Search Results

1

Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Pliskin M, Beahrs JR, Prall D, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Tadros NN, Gange SN, Roehrborn CG. McVary KT, et al. Among authors: gittelman mc. J Urol. 2021 Sep;206(3):715-724. doi: 10.1097/JU.0000000000001778. Epub 2021 Apr 19. J Urol. 2021. PMID: 33872051 Clinical Trial.

2

Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group.

Roehrborn CG, Boyle P, Bergner D, Gray T, Gittelman M, Shown T, Melman A, Bracken RB, deVere White R, Taylor A, Wang D, Waldstreicher J. Roehrborn CG, et al. Urology. 1999 Oct;54(4):662-9. doi: 10.1016/s0090-4295(99)00232-0. Urology. 1999. PMID: 10510925 Clinical Trial.

3

Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence.

Dmochowski RR, Davila GW, Zinner NR, Gittelman MC, Saltzstein DR, Lyttle S, Sanders SW; Transdermal Oxybutynin Study Group. Dmochowski RR, et al. Among authors: gittelman mc. J Urol. 2002 Aug;168(2):580-6. J Urol. 2002. PMID: 12131314 Clinical Trial.

4

A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.

Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, Pearson J, Krupa D, Bach M, Drisko J; Rofecoxib Prostatitis Investigator Team. Nickel JC, et al. J Urol. 2003 Apr;169(4):1401-5. doi: 10.1097/01.ju.0000054983.45096.16. J Urol. 2003. PMID: 12629372 Clinical Trial.

5

First dose efficacy of alfuzosin once daily in men with symptomatic benign prostatic hyperplasia.

Marks LS, Roehrborn CG, Gittelman M, Kim D, Forrest J, Jacobs S. Marks LS, et al. Urology. 2003 Nov;62(5):888-93. doi: 10.1016/s0090-4295(03)00657-5. Urology. 2003. PMID: 14624914 Clinical Trial.

6

Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.

Roehrborn CG, Bruskewitz R, Nickel JC, McConnell JD, Saltzman B, Gittelman MC, Malek GH, Gottesman JE, Suryawanshi S, Drisko J, Meehan A, Waldstreicher J; Proscar Long-Term Efficacy and Safety Study Group. Roehrborn CG, et al. Among authors: gittelman mc. J Urol. 2004 Mar;171(3):1194-8. doi: 10.1097/01.ju.0000112918.74410.94. J Urol. 2004. PMID: 14767299 Clinical Trial.

7

Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia.

Auerbach SM, Gittelman M, Mazzu A, Cihon F, Sundaresan P, White WB. Auerbach SM, et al. Urology. 2004 Nov;64(5):998-1003; discussion 1003-4. doi: 10.1016/j.urology.2004.07.038. Urology. 2004. PMID: 15533493 Clinical Trial.

8

Dutasteride improves objective and subjective disease measures in men with benign prostatic hyperplasia and modest or severe prostate enlargement.

Gittelman M, Ramsdell J, Young J, McNicholas T. Gittelman M, et al. J Urol. 2006 Sep;176(3):1045-50; discussion 1050. doi: 10.1016/j.juro.2006.04.032. J Urol. 2006. PMID: 16890688 Clinical Trial.

9

A 1-year, open label, randomized phase II dose finding study of degarelix for the treatment of prostate cancer in North America.

Gittelman M, Pommerville PJ, Persson BE, Jensen JK, Olesen TK; Degarelix Study Group. Gittelman M, et al. J Urol. 2008 Nov;180(5):1986-92. doi: 10.1016/j.juro.2008.07.033. Epub 2008 Sep 17. J Urol. 2008. PMID: 18801505 Clinical Trial.

10

Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies.

Marks LS, Gittelman MC, Hill LA, Volinn W, Hoel G. Marks LS, et al. Among authors: gittelman mc. J Urol. 2009 Jun;181(6):2634-40. doi: 10.1016/j.juro.2009.02.034. Epub 2009 Apr 16. J Urol. 2009. PMID: 19371887 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters